Personalized Medical Care & Dedicated International Patient Concierge
Medical Guide
Pico Laser and Pigmentation: Why the Target Decides
Medically reviewed by Dr. Choi Ji Eun, MD, Director, Toxnfill Hongdae Most articles about pigmentation lasers are about the laser. This one is about the pigment, because that is wh
Schedule a ConsultationMedically reviewed by Dr. Choi Ji Eun, MD, Director, Toxnfill Hongdae
Most articles about pigmentation lasers are about the laser. This one is about the pigment, because that is where the difficulty actually lives.
The device side of the question is straightforward enough to state in a sentence. Toxnfill Hongdae describes its Pico Toning treatment as using very short, very fast pulses of energy aimed at the pigment, breaking it into fine particles so that overall skin tone and the appearance of blemishes, melasma, freckles and sun spots can improve. That is what the machine does. It does the same thing on everyone.
What is not the same on everyone is what the energy meets. "Pigmentation" is not a diagnosis. It is a description of an appearance, and several genuinely different conditions produce that appearance. Some of them sit shallow and respond well. Some sit deeper and move slowly. And some are driven by a process that is still running, which no laser switches off. Those three groups behave so differently that the same treatment, delivered competently, produces a delighted patient in one case and a disappointed one in another — and the difference was decided before anyone turned a device on.
"Pigmentation" Names Several Conditions, Not One
Look in a mirror and brown is brown. Look through a clinician's lens and the differences are substantial.
The StatPearls chapter on melasma, published on the National Library of Medicine's NCBI Bookshelf, sets out the problem directly in its stated learning objectives: the clinician's task is to differentiate melasma from other facial hyperpigmentation disorders, including postinflammatory hyperpigmentation, lentigines and drug-induced pigmentation, using clinical and diagnostic features. Its own differential list is longer still, naming lichen planus pigmentosus, erythema dyschromicum perstans, pigmented contact dermatitis and exogenous ochronosis among the conditions that mimic melasma in distribution or color.
The StatPearls chapter on postinflammatory hyperpigmentation gives the mirror image of that list, naming melasma, solar lentigines, tinea versicolor, acanthosis nigricans, macular amyloidosis, ochronosis, discoid lupus erythematosus and others among the conditions it must be told apart from.
Two clinical references, two long lists, and a great deal of overlap between them. That is the honest picture. A patient looking at their own face is seeing the final common appearance of a set of conditions with different causes, different depths, different natural histories and different responses to treatment.
The American Academy of Dermatology adds a consequence that belongs at the front of any article like this. Writing about age spots, it states that a dermatologist can tell you whether an age spot is actually an age spot, because seborrheic keratoses, actinic keratoses and skin cancer also become more common on skin as it ages. It then gives the reason this matters: using a treatment to fade what is in fact a skin cancer gives the cancer time to grow and possibly spread, while skin cancer caught early is highly treatable. Not every brown mark is a cosmetic problem, and that determination is made by examination.
Three Broad Groups, and Why They Behave Differently
Clinically the distinctions are finer than this, but for a patient trying to understand their own situation, three groups carry most of the useful information.
Pigment that sits shallow and is not being actively driven. Discrete sun-related spots and freckles sit in this group. The pigment is concentrated, it is held near the surface, and nothing is currently manufacturing more of it except ultraviolet exposure. This is the group that behaves the way patients expect a laser to behave, and the Academy notes that one or two laser treatments can address age spots relatively quickly, with longer-lasting results than a fading cream.** Pigment that has settled deeper.** The StatPearls chapter on postinflammatory hyperpigmentation draws this line sharply. When pigment accumulates in the upper layers it presents as brown discoloration and tends to improve more readily; when inflammation has been more severe or prolonged, pigment escapes deeper and is engulfed by scavenger cells there, producing a blue-gray appearance that is more persistent and, in the chapter's own words, may be permanent. Its prognosis section puts numbers on that difference: upper-layer pigmentation typically resolves or improves substantially within six to twelve months, while deeper pigmentation improves slowly and may not clear at all.** Pigment driven by a process that is still running.** Melasma is the clearest example. The StatPearls chapter describes it as a chronic, relapsing condition in which long-term control and prevention of recurrence matter as much as initial clearance, and states that clinical improvement is frequently transient in the absence of sustained photoprotection and maintenance. It goes further, framing melasma as involving interactions among skin cells, connective-tissue cells, blood-vessel cells and inflammatory mediators, with dermal changes including basement membrane disruption, sun-related connective-tissue change, new vessel formation and low-grade inflammation increasingly recognized as integral to its persistence. That is not a description of a static deposit waiting to be removed. It is a description of an ongoing biological process.
Why People Say a Treatment "Did Not Work" When It Did Its Job
The third group is where the most common disappointment comes from, and it is usually a misunderstanding rather than a failure.
If the underlying process is still active, then clearing the pigment currently present does not stop the condition from producing more. The pigment fades, the patient is pleased, and then over subsequent months some of it returns — not because the treatment was ineffective, but because the treatment addressed the deposit rather than the driver. The StatPearls melasma chapter is unambiguous about this, listing among its educational objectives that patient awareness of treatment limitations, recurrence risk and the necessity of ongoing preventive strategies should be improved. It also notes that therapeutic durability improves when the plan explicitly includes a maintenance phase.
The same chapter names the specific factors that influence relapse: ongoing light exposure, hormonal drivers, skin phototype, how much of the pigment sits deeper, and adherence to photoprotection and maintenance. Four of those five are outside the treatment room.
There is a second version of "it did not work" that is worth naming separately. A face often carries more than one kind of pigmentation at once — sun-related spots over a background of a relapsing condition, with older marks from inflammation in the lower cheeks. When a treatment lifts the responsive component first, the remaining component can briefly look more distinct by contrast. That is a stage in the sequence rather than evidence of failure, and it is the kind of thing a clinician should describe before it happens rather than explain afterward.
Treating the Wrong Kind Aggressively Makes It Worse
This is the single most important thing a patient can understand before consenting to anything, because it inverts the usual intuition that a stronger treatment is a better one.
Pigment production is an inflammatory response. The StatPearls chapter on postinflammatory hyperpigmentation describes the mechanism: inflammation from any skin insult — including dermatologic procedures — triggers inflammatory mediators, prostaglandins and reactive oxygen species, which stimulate pigment cells to produce excess pigment that is then transferred into neighboring cells and, in some cases, leaks deeper. Its list of triggers explicitly includes dermatologic procedures alongside acne, eczema and trauma.
So a treatment that generates more inflammation than the skin can absorb does not simply fail to help. It can supply exactly the stimulus that causes the problem it was meant to treat. The same chapter states that treatments such as chemical peels or lasers, if not carefully tailored, may exacerbate inflammation and worsen pigmentation, particularly in people with darker skin tones. The melasma chapter says the same thing from its own side, naming procedure-associated pigment change as a major risk when technique or photoprotection are inadequate, and advising patients with melasma to avoid irritant skincare practices, aggressive exfoliation and unmonitored combination lightening agents.
There is a reason this risk is not distributed evenly. The StatPearls reference on laser recommendations by skin phototype explains that when more pigment sits in the upper layer of the skin, more of the delivered energy is absorbed there rather than reaching its intended target, and it sets out the appropriate responses: longer wavelengths, lower energy densities, lower treatment densities and cooling of the skin surface. It states plainly that the risk of pigment change after light-based procedures is higher in the deeper phototypes.
Read those together and the conclusion is uncomfortable but clear. In the skin most likely to be affected by pigmentation, the margin for aggressive treatment is smallest. A clinician who proposes a conservative, incremental approach for a difficult pigment pattern is not offering a weaker service. They are respecting the mechanism.
What a Clinician Is Trying to Establish Before Choosing Anything
Given all of the above, the consultation is not a formality preceding the treatment. It is the part that determines whether the treatment helps.
The questions a clinician is working through are concrete. What kind of pigmentation is this, and is more than one kind present? Is anything about this mark suspicious rather than cosmetic? How is the pigment distributed — symmetrically across sun-exposed areas, or in the pattern of a previous rash or injury? How long has it been there, and what was happening when it started? Is there a hormonal context, a pregnancy, a medication? Is there a family history? What is the phototype, and what has this skin done after previous inflammation or previous procedures? And is the causative process, if there is one, still active?
The StatPearls melasma chapter describes a history focused on onset, chronicity and known triggers, including cumulative sun exposure, pregnancy and hormonal medication use, with physical examination looking for symmetrical patches with irregular borders and uniform coloration in characteristic facial distributions. It notes that the condition is diagnosed clinically, that routine laboratory testing is not indicated in typical cases, and — a point worth knowing because it contradicts a widely repeated claim — that examination under a Wood lamp gives inconsistent results, particularly in darker phototypes, and should not be used to guide prognosis or treatment decisions. It describes dermoscopy as the more useful adjunct, allowing pigment patterns and vascular structures to be seen.
Toxnfill Hongdae documents a process consistent with that emphasis. For its laser skin treatments generally, it states that the clinician first assesses the skin concern, the pigmentation pattern, the skin's condition, the medical history, current medications and previous treatments, and only then selects the laser type and settings according to the individual's condition. For Pico Toning specifically, its documented consultation is an evaluation of the pigmentation and the overall skin condition before any decision is made about whether the treatment is appropriate at all. It also lists circumstances in which treatment may need to be postponed or modified, including active skin infection, significant irritation or open wounds, certain photosensitive conditions or medications, and an increased risk of abnormal pigmentation.
That last item is the whole argument in a single line on a clinic page.
The Part That Happens Between and After Sessions
For the relapsing group in particular, most of the work is done by the patient, in ordinary daylight, on days when nothing is scheduled.
Ultraviolet exposure is the most consistent and most modifiable driver. The StatPearls melasma chapter identifies chronic light exposure as contributing to both onset and relapse, and adds a detail that changes what adequate protection means: visible light, particularly short-wavelength blue light, is a clinically significant contributor, and the pigmentation it induces may be more intense and longer-lasting than that induced by ultraviolet light, especially in darker phototypes. Its patient-education guidance accordingly recommends tinted photoprotection containing iron oxides and realistic reapplication habits that fit a working day.
The practical framework is well covered by public health sources. The Centers for Disease Control and Prevention states that ultraviolet rays reach you on cloudy and cool days and reflect off water, cement, sand and snow, that in the continental United States they are strongest from 10 a.m. to 4 p.m. daylight saving time, and that protection is warranted whenever the UV Index is 3 or higher, with shade, tightly woven long sleeves, a hat with a brim all the way around and sunglasses as the measures it names. The US Food and Drug Administration's consumer guidance on sunscreen covers choosing a broad-spectrum product and applying and reapplying it properly. MedlinePlus, from the National Library of Medicine, maintains a plain-language overview of skin pigmentation disorders for patients who want to read about the conditions themselves.
Beyond light, the other lever is not adding inflammation. The postinflammatory hyperpigmentation chapter's deterrence guidance is gentle skincare, avoiding picking or scratching lesions, daily sun protection, and treating any underlying inflammatory condition early so that the pigmentation has less cause to form in the first place. Toxnfill Hongdae's own aftercare for Pico Toning is in the same register: moisturize, use sunscreen, keep scrubs, peeling treatments and irritating actives such as retinol out of the routine immediately afterward, and do not pick any scabs that form.
What a Realistic Good Outcome Looks Like
Expectations should be set per condition, not per device.
For shallow, sun-related spots that are no longer being actively driven, a good outcome is substantial fading or clearance of the treated marks, holding as long as photoprotection holds. The Academy's own framing is worth keeping in mind: most results are not permanent, because skin continues to age, and someone with extensive sun damage will likely continue to see new spots appear.
For pigment that has settled deeper, a good outcome is meaningful improvement in appearance over a longer period rather than erasure. The postinflammatory hyperpigmentation chapter's own prognosis — slow improvement, possibly permanent in the deeper form — is the honest baseline, and it also notes that treatment lasting months to years is often required, with the expectation set that improvement is slow and recurrences are common.
For pigmentation driven by an active process, a good outcome is control. The melasma chapter frames management around long-term control and prevention of recurrence rather than short-term clearance, with an explicit maintenance phase, and notes that significant improvement is often achieved with consistent therapy while complete and durable clearance is less predictable. That is not a disappointing goal; it is the correct goal, and a plan built around it will outperform a plan built around clearance.
Toxnfill Hongdae's documented position is compatible with all three. It describes improvement from its laser treatments as developing gradually over weeks and sessions, with longevity varying according to the condition, the treatment type and ongoing sun protection, and its stated claim guidance for Pico Toning is that it may be described as helping improve pigmentation, melasma, freckles, sun spots, blemishes and overall brightness, while claims of permanent or personalized clinical outcomes are to be avoided.
Why a Device Name on a Clinic Page Tells You Nothing
Everything above leads to one practical conclusion about how to read clinic marketing.
A device name tells you what equipment is in the building. It does not tell you whether the pigment on your face is the kind that equipment suits, because that question has not been asked yet. Two people can book the same named treatment and be in entirely different clinical situations, and the treatment is not what distinguishes their outcomes.
What does distinguish them is whether anyone established what the pigmentation is before selecting anything, whether the settings were chosen for that particular skin rather than applied as a default, whether the plan includes what happens between sessions, and whether the risk of making things worse was assessed honestly. The Academy makes the general version of this point about cosmetic procedures: selecting the right procedure and performing it safely requires in-depth knowledge of the skin, which is why it recommends that these treatments be performed by a board-certified dermatologist. Toxnfill Hongdae's own documentation says the equivalent from the other direction — that its laser settings, energy levels and techniques are individualized and should be confirmed during consultation.
So the useful question to bring to a clinic is not whether they have a particular laser. It is what they think your pigmentation is, what they are basing that on, and what would make them change their mind.
Toxnfill Hongdae takes inquiries through its contact page, its clinic profile sets out how it describes its treatment categories, and its medical team page lists the physicians who carry out the assessment.
The Bottom Line
- "Pigmentation" describes an appearance, not a diagnosis; StatPearls differential lists for melasma and for postinflammatory hyperpigmentation each run to a dozen conditions that look similar and behave differently.
- Shallow, sun-related pigment tends to respond well; pigment that has settled deeper appears blue-gray, improves slowly and may be permanent; pigment driven by an ongoing process returns unless the driver is managed.
- Treating the wrong kind aggressively can worsen it, because inflammation is itself a stimulus for pigment production, and StatPearls names dermatologic procedures among the triggers.
- The risk is unevenly distributed: published guidance on laser use by skin phototype calls for lower energy and treatment densities, longer wavelengths and surface cooling when more pigment sits in the upper layer, and notes higher risk of pigment change in deeper phototypes.
- A device name tells you what equipment a clinic owns; only an examination tells you whether your particular pigment suits it.
Frequently Asked Questions
Why do two people with similar-looking marks get different results?
Because similar-looking marks are frequently different conditions. The StatPearls chapters on melasma and on postinflammatory hyperpigmentation each list a dozen or more disorders that can produce comparable facial discoloration, including solar lentigines, lichen planus pigmentosus, drug-induced pigmentation and pigmented contact dermatitis. Different conditions sit at different depths and have different natural histories, so the same competent treatment produces different outcomes.
My pigmentation faded and then came back. Did the treatment fail?
Not necessarily. If the underlying condition is one that is still being driven, clearing the pigment present does not stop more being produced. The StatPearls melasma chapter describes the condition as chronic and relapsing, with improvement frequently transient in the absence of sustained photoprotection and maintenance, and identifies ongoing light exposure, hormonal drivers, phototype, depth and adherence as the factors influencing relapse.
Can a laser make pigmentation worse?
Yes, and it is worth understanding how. The StatPearls chapter on postinflammatory hyperpigmentation records that inflammation from skin insults including dermatologic procedures triggers mediators that stimulate excess pigment production, and states that lasers and chemical peels, if not carefully tailored, may worsen pigmentation, particularly in people with darker skin tones. This is why conservative settings and a careful assessment matter more than device branding.
What is the clinician actually looking for at the consultation?
What kind of pigmentation it is, whether more than one kind is present, how it is distributed, when and in what circumstances it began, whether there is a hormonal or medication context, what the phototype is, and how the skin has behaved after previous inflammation. Toxnfill Hongdae documents assessing the skin concern, the pigmentation pattern, the skin's condition, medical history, medications and previous treatments before the laser type and settings are selected.
Does what I do between appointments really change the result?
For the relapsing group it is most of the result. The StatPearls melasma chapter identifies chronic light exposure as the most consistent modifiable driver and notes that visible light, particularly blue light, can induce pigmentation that is more intense and longer-lasting than that from ultraviolet light. The Centers for Disease Control and Prevention notes that ultraviolet rays reach you on cloudy days and reflect off water, cement, sand and snow, and recommends shade, covering clothing, a brimmed hat and sunglasses.
What should I expect a good outcome to look like?
It depends which kind you have. For shallow sun-related spots, substantial fading that holds as long as photoprotection does — though the American Academy of Dermatology notes results are rarely permanent because skin keeps aging. For deeper pigment, gradual improvement rather than erasure. For a relapsing condition, control with a maintenance phase rather than a finish line. Toxnfill Hongdae describes improvement as developing gradually and advises against claims of permanent or personalized clinical outcomes.
This article is for general informational purposes, does not constitute individualized medical advice, and is not a self-diagnosis tool. Pigmentation disorders can look alike and require examination to tell apart, and some pigmented lesions are not cosmetic at all. Only a qualified dermatologist or physician who has examined your skin in person can determine what your pigmentation is and whether any laser treatment is appropriate for it.
Clinical Notice: Individual treatment outcomes and recovery timelines may vary depending on skin condition and personal physiology. Temporary redness, mild swelling, or bruising may occur after treatment; a pre-procedure physician consultation is always conducted.
More Articles
Continue reading our clinical guides.
Toxnfill Hongdae Dermatologist: Meet Dr. Chang Ye Ji
Medically reviewed by Dr. Chang Ye Ji, MD, Chief Director, Toxnfill Hongdae The lead dermatologist at Toxnfill Hongdae is Dr. Chang Ye Ji, who serves as the branch's Chief Director
Learn More
Korean Dermatology Residency Training: How Doctors Qualify
Medically reviewed by Dr. Chang Ye Ji, MD, Chief Director, Toxnfill Hongdae Korean dermatology residency training follows a sequence that will look broadly familiar to an American
Learn More
In-Person Consultation at a Korean Dermatology Clinic
Medically reviewed by Dr. Chang Ye Ji, MD, Chief Director, Toxnfill Hongdae An in person consultation at a Korea dermatology clinic is a working appointment with a defined shape: h
Learn More